Orbital infarction syndrome in nephrotic syndrome patient with extensive carotid arteries occlusion.
Orbital infarction syndrome is defined as ischemia of global intraorbital structures such as extraocular muscles, optic nerves, and retina. The most common cause of this syndrome is carotid arterial occlusion. Other causes include vasculitis, vasospasm, and compression of intraorbital circulation. There has never been reported a case of orbital infarction syndrome in nephrotic syndrome patient. We present a case of 42-year-old Thai man with underlying disease nephrotic syndrome presented with abrupt onset of headache at left temporal area, horizontal diplopia, limitation of eye movement in all directions, ptosis, and blurred vision on the left eye. He was treated with pulse methylprednisolone intravenously for 3 days. Leg edema was improved however, the eye symptoms persisted. There was no evidence of hypercoagulable state. Magnetic resonance imaging (MRI), magnetic resonance angiography (MRA) revealed loss of signal intensity at left internal carotid artery from base of skull to intracavernous part. Cerebral angiography demonstrated complete occlusion of left common carotid artery. After the anticoagulant treatment, his symptoms were gradually improved. The cause of extensive carotid arterial occlusion in this patient is most likely from hypercoagulable state. Although it was negative for hypercoagulable state evidence, the authors assume that the high dose steroid treatment could lead to remission of nephrotic syndrome and resulting in the resolution of hypercoagulable state.
Wiroteurairueng
Thaddao
T
Division ofNeurology, Department ofMedicine, Faculty ofMedicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Poungvarin
Niphon
N
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D002340:Carotid Artery Diseases / Q000503:physiopathology; D016893:Carotid Stenosis / Q000503:physiopathology*; D002544:Cerebral Infarction / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008297:Male; D009916:Orbital Diseases / Q000209:etiology* / Q000503:physiopathology; D013577:Syndrome; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin